دورة المؤشرنت للتحليل الفني
50 دينار كويتي
Nbix حلو للمضاربه بو ابراهيم ( طبي ) :) دموي
- بادئ الموضوع circle
- تاريخ البدء
FreeTrader
عضو محترف
على غريمات صغيره مو حلو
قاعد اطالع الارجنتين شنو سوو بالصرب
6-0
قاعد اطالع الارجنتين شنو سوو بالصرب
6-0APcircle قال:بو ابراهيم اعتقد ان الخبلر المفروض ما ينزل السهم هالكثر وممكن يرتد شوي ويعدل اخر السوق ..
معطينه داونقريد الىال14 اعتقد من ال 22 ... على العموم شكل السالفه فيها لعبه .... واحتمالات صعوده احس فيها مثل الم الفقرات
Neurocrine Shares Plummet
Friday June 16, 10:22 am ET
Neurocrine Shares Drop on FDA Approval Delay for Sleep Aid
SAN DIEGO, Calif. (AP) -- Shares of drug developer Neurocrine Biosciences Inc. plummeted in Friday morning trading after the company said it may have to conduct additional clinical tests on its sleeping drug candidate.
ADVERTISEMENT
The stock fell $3.02, or 16 percent, to $16.35 on the Nasdaq. The announcement came after the market closed Thursday, with the stock finishing at $19.37 on the Nasdaq.
The company said it requested a meeting with the Food and Drug Administration to find out what is necessary to receive approval for indiplon. The company received correspondence from the FDA last month, signaling it needed more time to review indiplon before giving it approval.
Baird U.S. Equity Research analyst Lawrence H. Neibor downgraded the stock Friday from "Underperform" to "Neutral" citing the delay in indiplon. He said, in a note to investors, the news means the 15-milligram dose of the drug will mostly likely be launched in early 2008 rather than in early 2007, prompting him to cut the price target to $14 from $22.
The positive scenario, he wrote, involves the drug launching in 2008 and hitting a peak market share of 15 percent in 2009. The negative scenario involves the drug not receiving approval and the smaller dose versions of it only receiving 2.5 percent of the market share.
هذا الخبر
FreeTrader
عضو محترف
يقولك ما عدى الفلتر وانت تقول شريت
هذا الي معور ظهرك الاسهم الطبيه عبالك بعالجونك
هذا الي معور ظهرك
الاسهم الطبيه عبالك بعالجونك
دورة المؤشرنت للتحليل الفني
50 دينار كويتي